Search research articles
Contact Us
Filters
Showing results (51-60 of 195) with videos related to
Page
of 20
Sort By:
Archives of General Psychiatry
|
January 1, 1980
Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms
D V Sheehan, J Ballenger, G Jacobsen
Managed Care Quarterly
|
December 13, 2002
Impact of formulary restrictions on the cost-effectiveness of antidepressant treatment
David V Sheehan, Pamela J Wright-Etter
Expert Review of Neurotherapeutics
|
August 14, 2009
Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders
Keming Gao, David V Sheehan, Joseph R Calabrese
Irish Medical Journal
|
January 1, 1983
Coumarin and cimetidine in malignant melanoma
R D Thornes, G Lynch, M V Sheehan
Psychopharmacology Bulletin
|
October 15, 2016
Assessment of Anxiety in Clinical Trials with Depressed Patients Using the Hamilton Depression Rating Scale
C Goldberger, J D Guelfi, D V Sheehan
Lancet (London, England)
|
August 7, 1982
Cimetidine and coumarin therapy of melanoma
R D Thornes, G Lynch, M V Sheehan
Scientific Reports
|
February 16, 2021
Optimal fishing effort benefits fisheries and conservation
Adam Rees, Emma V Sheehan, Martin J Attrill
International Journal of Psychiatry in Medicine
|
January 1, 1980
Monoamine oxidase inhibitors: prescription and patient management
D V Sheehan, J B Claycomb, N Kouretas
Appetite
|
July 22, 2006
Exposure, health information and flavour-masking strategies for improving the sensory quality of probiotic juice
T Luckow, V Sheehan, G Fitzgerald, et al.
Psychopharmacology Bulletin
|
May 22, 2007
The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder
David V Sheehan, Kathy Harnett Sheehan, B A Raj
Page
of 20
Search research articles
Search
Showing results (51-60 of 195) with videos related to
Sort By:
Page
of 20
Archives of General Psychiatry
|
January 1, 1980
Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms
D V Sheehan, J Ballenger, G Jacobsen
Managed Care Quarterly
|
December 13, 2002
Impact of formulary restrictions on the cost-effectiveness of antidepressant treatment
David V Sheehan, Pamela J Wright-Etter
Expert Review of Neurotherapeutics
|
August 14, 2009
Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders
Keming Gao, David V Sheehan, Joseph R Calabrese
Irish Medical Journal
|
January 1, 1983
Coumarin and cimetidine in malignant melanoma
R D Thornes, G Lynch, M V Sheehan
Psychopharmacology Bulletin
|
October 15, 2016
Assessment of Anxiety in Clinical Trials with Depressed Patients Using the Hamilton Depression Rating Scale
C Goldberger, J D Guelfi, D V Sheehan
Lancet (London, England)
|
August 7, 1982
Cimetidine and coumarin therapy of melanoma
R D Thornes, G Lynch, M V Sheehan
Scientific Reports
|
February 16, 2021
Optimal fishing effort benefits fisheries and conservation
Adam Rees, Emma V Sheehan, Martin J Attrill
International Journal of Psychiatry in Medicine
|
January 1, 1980
Monoamine oxidase inhibitors: prescription and patient management
D V Sheehan, J B Claycomb, N Kouretas
Appetite
|
July 22, 2006
Exposure, health information and flavour-masking strategies for improving the sensory quality of probiotic juice
T Luckow, V Sheehan, G Fitzgerald, et al.
Psychopharmacology Bulletin
|
May 22, 2007
The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder
David V Sheehan, Kathy Harnett Sheehan, B A Raj
Page
of 20